Premium
Ibrutinib and idelalisib in the management of CLL‐associated autoimmune cytopenias: a study from the FILO group
Author(s) -
Quinquenel Anne,
Godet Sophie,
Dartigeas Caroline,
Ysebaert Loïc,
Dupuis Jehan,
Ohanyan Haykanush,
Collig Aude,
Gilardin Laurent,
Lepretre Stéphane,
Dilhuydy MarieSarah,
Vig Marguerite,
Guibert Sophie,
Dmytruk Natalia,
Durot Eric,
Ghez David,
Roos Weil Damien,
Béné MarieChristine,
Toussaint Elise,
Merabet Fatiha,
Lévy Vincent,
Delmer Alain,
Aurran Thérèse
Publication year - 2019
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.25480
Subject(s) - ibrutinib , idelalisib , medicine , rituximab , oncology , lymphoma , chronic lymphocytic leukemia , leukemia